TPX2 silencing exerts anti-tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway

Hepatocellular carcinoma (HCC) is one of the primary causes of cancer-associated deaths worldwide. Current treatment methods include surgical resection, chemotherapy and radiotherapy; however the curative rate remains low, thus novel treatments are required. The aim of the present study was to inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Dan-Hong, Jian, Jie, Li, Shuang, Zhang, Yan, Liu, Li-Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844623/
https://www.ncbi.nlm.nih.gov/pubmed/31638175
http://dx.doi.org/10.3892/ijmm.2019.4371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844623/
https://www.ncbi.nlm.nih.gov/pubmed/31638175
http://dx.doi.org/10.3892/ijmm.2019.4371

Ejemplares similares